Bristol-Myers Squibb Company (NYSE:BMY) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Bristol-Myers Squibb Third Quarter 2024 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded.
Bristol Myers Squibb Co (BMY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 249,072 | $12,886,985 | -2% | 0.05% |
| 2. | Skylands Capital Charles Paquelet | 181,075 | $9,368,821 | -18% | 1.27% |
| 3. | Lee Munder Capital Group Lee Munder | 7,092 | $366,940 | -1% | 0.02% |
| 4. | Bailard Inc Thomas Bailard | 5,672 | $293,469 | -63% | 0% |
| 5. | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $49.78 | 2,000 | Officer | 82,672 | 2023-12-05 | Filing | |
| $48.86 | 3,071 | Officer | 79,384 | 2023-11-28 | Filing | |
| $49.81 | 8,500 | Director | 35,500 | 2023-11-20 | Filing | |
| $54.50 | 9,174 | Director | 22,109 | 2020-06-15 | Filing | |
| $58.90 | 88 | Director | 7,189 | 2019-12-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $61.25 | 17,986 | Officer | 27,868 | 2023-08-24 | Filing | |
| $61.14 | 732 | Officer | 6,584 | 2023-08-03 | Filing | |
| $67.06 | 50,385 | Officer | 47,751 | 2023-05-03 | Filing | |
| $74.65 | 240,000 | Officer, Director | 236,104 | 2023-02-06 | Filing | |
| $74.69 | 11,183 | Officer | 23,043 | 2023-02-06 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 198,159,772 | $10,167,577,900 | 0.22% | |
| 2. | 168,103,766 | $8,625,404,241 | 0.21% | |
| 3. | 90,048,274 | $4,620,376,928 | 0.49% | |
| 4. | 89,446,206 | $4,589,484,830 | 0.22% | |
| 5. | 61,528,492 | $3,156,982,203 | 0.7% |
News See All
Jim Cramer’s Latest Game Plan: 20 Stocks to Watch
Jim Cramer, the host of Mad Money, recently advised investors to maintain composure as major companies release their earnings this week.
Bristol-Myers Squibb Company (BMY): A Bull Case Theory
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on BMY.
10 Best Medical Stocks to Buy Now
The medical and healthcare industry is one of the largest globally, with a steady demand for products and services due to the biological nature of humans. Stocks like Pfizer Inc.
Jim Cramer's Exclusive List of 9 YEV Stocks
To navigate this market, he developed a three-part evaluation framework, which he refers to as the YEV test.
10 Buzzing AI Health Stocks
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively, by 2030, amounting ...
Dividend Achievers List: Top 15
Dividend investing has become increasingly popular over time, as generating regular income remains a key focus for investors.
8 Dividend Giants with Lowest Short Interest in 2024
Short sellers have faced significant challenges over the past few years, as the market's ongoing rally has not been favorable to them, with 2023 being no exception.
10 Best Beaten Down Dividend Stocks to Invest in Now
Dividend stocks have faced challenges over the past year due to the rising focus on tech stocks. However, the value of income remains strong, and investors haven't overlooked dividend equities.
Bristol-Myers Squibb Company (NYSE:BMY) Q2 2024 Earnings Call Transcript
Operator: Good day and welcome to the Bristol Myers Squibb Second Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
Billionaire Hedge Funds
